HC Wainwright & Co. reiterated coverage on TherapeuticsMD with a new price target
$TXMD
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of TherapeuticsMD with a rating of Buy and set a new price target of $3.00 from $4.00 previously